Stay Tuned to the LDL Controversy

March 2017

Debate continues about when to monitor and how to manage LDL.

We know the new thinking is to use target DOSES of statins to reduce CV risk...instead of titrating to a specific LDL goal.

But don't use a "fire and forget" approach.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote